Apogee is pitching APG777 as a 'best-in-class' IL-13 inhibitor that could offer robust efficacy and less-frequent dosing than ...

It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...

The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...

The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

Looking back over the past five years, it's clear that healthcare professionals (HCPs) have faced incredible pressure and ...

In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...

Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...